Group One Trading’s Purple Biotech PPBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.51K Buy
+900
New +$3.04K ﹤0.01% 7095
2026
Q1
Sell
-100
Closed -$658 8496
2025
Q4
$658 Buy
+100
New +$725 ﹤0.01% 7775
2025
Q3
Sell
-50
Closed -$1.18K 8980
2025
Q2
$1.18K Sell
50
-480
-91% -$11.9K ﹤0.01% 7525
2025
Q1
$14.4K Sell
530
-130
-20% -$4.16K ﹤0.01% 6030
2024
Q4
$31K Buy
+660
New +$25.4K ﹤0.01% 5409
2023
Q3
Sell
-74
Closed -$20.6K 8141
2023
Q2
$20.6K Sell
74
-298
-80% -$107K ﹤0.01% 5976
2023
Q1
$131K Buy
+372
New +$139K ﹤0.01% 4049
2022
Q4
Sell
-26
Closed -$11K 7903
2022
Q3
$11K Sell
26
-177
-87% -$82.7K ﹤0.01% 6445
2022
Q2
$97K Sell
203
-4
-2% -$2.4K ﹤0.01% 5013
2022
Q1
$164K Sell
207
-3
-1% -$1.94K ﹤0.01% 5011
2021
Q4
$163K Sell
210
-8
-4% -$6.82K ﹤0.01% 5285
2021
Q3
$198K Buy
218
+56
+35% +$54.2K ﹤0.01% 5183
2021
Q2
$158K Buy
162
+142
+710% +$130K ﹤0.01% 5488
2021
Q1
$17K Buy
+20
New +$18.7K ﹤0.01% 6829

Other funds holding PPBT

Group One Trading's PPBT Position: Q2 2026 in Review

Group One Trading sold out of Purple Biotech (PPBT) in Q2 2026, closing a stake of 20 shares — an estimated $67 sold.

Group One Trading first reported a position in PPBT in Q1 2021 and held it in 18 quarters. The position peaked at $214K in Q3 2021. 13 funds tracked by Wall St. Rank hold PPBT as of Q2 2026.

  • Group One Trading reported no remaining Purple Biotech position as of Q2 2026 after selling out during the quarter.
  • Group One Trading sold 20 Purple Biotech shares in Q2 2026, an estimated $67.
  • Group One Trading first reported a position in Purple Biotech in Q1 2021 and held it in 18 quarters.
  • Group One Trading's Purple Biotech position peaked at $214K in Q3 2021.
  • 13 funds tracked by Wall St. Rank held Purple Biotech as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.